Contrast-Enhanced Ultrasound Imaging for Diagnosing Recurrent Renal Cell Carcinoma (RCC) Post Ablation
Status:
Recruiting
Trial end date:
2028-02-01
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well contrast-enhanced ultrasound (CEUS) works for diagnosing
patients with renal cell cancer (RCC) that has come back (recurrent) after an ablation.
Diagnostic imaging, such as CEUS, may help find and monitor long term renal cell cancer
recurrence following cryo or microwave ablation.